Drug
Budesonide
Budesonide: highest development phase Approved, developed by AstraZeneca, Merck, Sandoz. 3 trial records tracked on RxWires.
- Highest phase
- Approved
- Developer
- AstraZeneca, Merck, Sandoz
Trials
| Drug | Phase | Indication |
|---|---|---|
| BREZTRI AEROSPHERE | Approved | |
| budesonide NCT00462592 | Phase 3 | Asthma |
| Budesonide NCT05429775 | Phase 1 |
Latest
No recent events.
Follow Budesonide on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.